BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17012840)

  • 1. Regulation of MAP kinases by the VHR dual-specific phosphatase: implications for cell growth and differentiation.
    Cerignoli F; Rahmouni S; Ronai Z; Mustelin T
    Cell Cycle; 2006 Oct; 5(19):2210-5. PubMed ID: 17012840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence.
    Rahmouni S; Cerignoli F; Alonso A; Tsutji T; Henkens R; Zhu C; Louis-dit-Sully C; Moutschen M; Jiang W; Mustelin T
    Nat Cell Biol; 2006 May; 8(5):524-31. PubMed ID: 16604064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase (JNK).
    Todd JL; Rigas JD; Rafty LA; Denu JM
    Oncogene; 2002 Apr; 21(16):2573-83. PubMed ID: 11971192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation.
    Alonso A; Saxena M; Williams S; Mustelin T
    J Biol Chem; 2001 Feb; 276(7):4766-71. PubMed ID: 11085983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway.
    Todd JL; Tanner KG; Denu JM
    J Biol Chem; 1999 May; 274(19):13271-80. PubMed ID: 10224087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VHR/DUSP3 phosphatase: structure, function and regulation.
    Pavic K; Duan G; Köhn M
    FEBS J; 2015 May; 282(10):1871-90. PubMed ID: 25757426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
    Reffas S; Schlegel W
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
    Arnoldussen YJ; Lorenzo PI; Pretorius ME; Waehre H; Risberg B; Maelandsmo GM; Danielsen HE; Saatcioglu F
    Cancer Res; 2008 Nov; 68(22):9255-64. PubMed ID: 19010898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation of VHR phosphatase by ZAP-70.
    Alonso A; Rahmouni S; Williams S; van Stipdonk M; Jaroszewski L; Godzik A; Abraham RT; Schoenberger SP; Mustelin T
    Nat Immunol; 2003 Jan; 4(1):44-8. PubMed ID: 12447358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin regulates MAP kinase phosphatase-1 induction in Hirc B cells via activation of both extracellular signal-regulated kinase (ERK) and c-Jun-N-terminal kinase (JNK).
    Byon JC; Dadke SS; Rulli S; Kusari AB; Kusari J
    Mol Cell Biochem; 2001 Feb; 218(1-2):131-8. PubMed ID: 11330828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation by arachidonic acid metabolites of the H2O2-induced stimulation of mitogen-activated protein kinases (extracellular-signal-regulated kinase and c-Jun NH2-terminal kinase).
    Tournier C; Thomas G; Pierre J; Jacquemin C; Pierre M; Saunier B
    Eur J Biochem; 1997 Mar; 244(2):587-95. PubMed ID: 9119028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR.
    Hao L; ElShamy WM
    Int J Cancer; 2007 Jul; 121(1):39-46. PubMed ID: 17278098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DUSP3/VHR: A Druggable Dual Phosphatase for Human Diseases.
    Monteiro LF; Ferruzo PYM; Russo LC; Farias JO; Forti FL
    Rev Physiol Biochem Pharmacol; 2019; 176():1-35. PubMed ID: 30069819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of ERK activity by VRK3-mediated activation of VHR phosphatase.
    Kang TH; Kim KT
    Nat Cell Biol; 2006 Aug; 8(8):863-9. PubMed ID: 16845380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
    Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a potent inhibitor of human dual-specific phosphatase, VHR, from computer-aided and NMR-based screening to cellular effects.
    Shi Z; Tabassum S; Jiang W; Zhang J; Mathur S; Wu J; Shi Y
    Chembiochem; 2007 Nov; 8(17):2092-9. PubMed ID: 17933004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
    Magi-Galluzzi C; Mishra R; Fiorentino M; Montironi R; Yao H; Capodieci P; Wishnow K; Kaplan I; Stork PJ; Loda M
    Lab Invest; 1997 Jan; 76(1):37-51. PubMed ID: 9010448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle cells.
    Bokemeyer D; Lindemann M; Kramer HJ
    Hypertension; 1998 Oct; 32(4):661-7. PubMed ID: 9774360
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.